Brief: Fennec Pharmaceuticals Reports Full Year And Fourth Quarter 2022 Financial Results

Fennec Pharmaceuticals

30/03/2023 11:13

March 30 (Reuters) - Fennec Pharmaceuticals Inc
 FENC.O :
    * FENNEC PHARMACEUTICALS REPORTS FULL YEAR AND FOURTH
QUARTER 2022
FINANCIAL RESULTS
    * QTRLY LOSS PER SHARE $0.26
    * FENNEC PHARMACEUTICALS - CASH AND CASH EQUIVALENTS ON HAND
AS OF
DE  31, 2022 WILL BE SUFFICIENT TO FUND PLANNED COMMERCIAL
ACTIVITIES FOR 2023
    * Q4 EARNINGS PER SHARE VIEW $-0.26 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNXb6LGVm 
Further company coverage:  FENC.O 

 ((Reuters.Briefs@thomsonreuters.com;))